TP53 |
lymphoblastoid cells |
Doxo |
Permissive
Robust
|
Homo sapiens |
GSE46991
...
|
MA0106.3
|
TP53 |
lymphoblastoid cells |
vehicle |
Permissive
|
Homo sapiens |
GSE46991
...
|
MA0106.3
|
TP53 |
lymphoblastoid cells |
nutlin-3 |
Permissive
|
Homo sapiens |
GSE46992
...
|
MA0106.3
|
TP53 |
lymphoblastoid cells |
ionizing radiation |
Permissive
Robust
|
Homo sapiens |
GSE46993
...
|
MA0106.3
|
TP53 |
BJ (fibroblasts) |
p53 KO |
Permissive
|
Homo sapiens |
GSE20076
...
|
MA0106.3
|
TP53 |
embryonic stem cells |
untreated |
Permissive
Robust
|
Mus musculus |
GSE26361
...
|
MA0106.3
|
TP53 |
embryonic stem cells |
adriamycin |
Permissive
Robust
|
Mus musculus |
GSE26361
...
|
MA0106.3
|
TP53 |
embryonic stem cells |
untreated |
Permissive
Robust
|
Mus musculus |
GSE26361
...
|
MA0106.3
|
TP53 |
embryonic stem cells |
adriamycin |
Permissive
Robust
|
Mus musculus |
GSE26361
...
|
MA0106.3
|
TP53 |
embryonic fibroblasts |
0.2ug/ml doxorubicin for 6h |
Permissive
Robust
|
Mus musculus |
GSE46240
...
|
MA0106.3
|
TP53 |
embryonic fibroblasts |
0.2ug/ml doxorubicin for 6h |
Permissive
|
Mus musculus |
GSE46240
...
|
MA0106.3
|
TP53 |
BJ (fibroblasts) |
none |
Permissive
Robust
|
Homo sapiens |
GSE55912
...
|
MA0106.3
|
TP53 |
BJ (fibroblasts) |
ionizing radiation |
Permissive
Robust
|
Homo sapiens |
GSE55912
...
|
MA0106.3
|
TP53 |
B-cells |
mock |
Permissive
|
Mus musculus |
GSE71175
...
|
MA0106.3
|
TP53 |
B-cells |
4h 7Gy |
Permissive
|
Mus musculus |
GSE71175
...
|
MA0106.3
|
TP53 |
spleen non-B-cells |
mock |
Permissive
|
Mus musculus |
GSE71175
...
|
MA0106.3
|
TP53 |
spleen non-B-cells |
4h 7Gy |
Permissive
|
Mus musculus |
GSE71175
...
|
MA0106.3
|
TP53 |
spleen |
4h 7Gy |
Permissive
|
Mus musculus |
GSE71175
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
irradiation 0h |
Permissive
Robust
|
Homo sapiens |
GSE100099
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
irradiation 1h |
Permissive
Robust
|
Homo sapiens |
GSE100099
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
irradiation 2.5h |
Permissive
Robust
|
Homo sapiens |
GSE100099
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
irradiation 4h |
Permissive
Robust
|
Homo sapiens |
GSE100099
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
irradiation 5h |
Permissive
Robust
|
Homo sapiens |
GSE100099
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
irradiation 7.5h |
Permissive
Robust
|
Homo sapiens |
GSE100099
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
irradiation 7.5h + Nutlin |
Permissive
Robust
|
Homo sapiens |
GSE100099
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
400 ng/mL neocarzinostatin for 3 h |
Permissive
Robust
|
Homo sapiens |
GSE101737
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
untreated |
Permissive
Robust
|
Homo sapiens |
GSE101737
...
|
MA0106.3
|
TP53 |
MCF-7 C4-12 (invasive breast ductal carcinoma) |
400 ng/mL neocarzinostatin for 3 h |
Permissive
Robust
|
Homo sapiens |
GSE101737
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
untreated |
Permissive
Robust
|
Homo sapiens |
GSE101737
...
|
MA0106.3
|
TP53 |
SW480 (colon adenocarcinoma) |
TNF-alpha 0 h |
Permissive
|
Homo sapiens |
GSE102796
...
|
MA0106.3
|
TP53 |
SW480 (colon adenocarcinoma) |
TNF-alpha 16 h |
Permissive
|
Homo sapiens |
GSE102796
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (+)-Nutlin |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (+)-Nutlin |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (+)-Nutlin |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1µM doxorubicin |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1µM doxorubicin |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1µM doxorubicin |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (-)-Nutlin |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (-)-Nutlin |
Permissive
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
B-cells |
lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (-)-Nutlin |
Permissive
Robust
|
Mus musculus |
GSE80186
...
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE86164
...
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
Nutlin |
Permissive
Robust
|
Homo sapiens |
GSE86164
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE86164
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
Nutlin |
Permissive
Robust
|
Homo sapiens |
GSE86164
...
|
MA0106.3
|
TP53 |
SJSA-1(osteosarcoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE86164
...
|
MA0106.3
|
TP53 |
SJSA-1(osteosarcoma) |
Nutlin |
Permissive
Robust
|
Homo sapiens |
GSE86164
...
|
MA0106.3
|
TP53 |
E14TG2a.4 (embryonic stem cells) |
Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml. |
Permissive
Robust
|
Mus musculus |
GSE70486
...
|
MA0106.3
|
TP53 |
E14TG2a.4 (embryonic stem cells) |
SB431542 (Tocris, #1614) were used at 10μM |
Permissive
Robust
|
Mus musculus |
GSE70486
...
|
MA0106.3
|
TP53 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 0h |
Permissive
|
Mus musculus |
GSE100962
...
|
MA0106.3
|
TP53 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 0.5h |
Permissive
|
Mus musculus |
GSE100962
...
|
MA0106.3
|
TP53 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 1h |
Permissive
|
Mus musculus |
GSE100962
...
|
MA0106.3
|
TP53 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 2h |
Permissive
|
Mus musculus |
GSE100962
...
|
MA0106.3
|
TP53 |
bone marrow-derived macrophages |
irradiated with 6Gy IR for 6h |
Permissive
Robust
|
Mus musculus |
GSE100962
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: Decitabine; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#45 |
Permissive
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #45 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #45 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#90 |
Permissive
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #90 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #90 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#104 |
Permissive
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #104 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #104 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#116 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #116 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
PHA-simulated human T-lynphocytes |
Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #116 |
Permissive
Robust
|
Homo sapiens |
GSE110368
...
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
Treatment: untreated control Sex: female Age:15 years Tissue: bone |
Permissive
|
Homo sapiens |
GSE110800
...
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
Treatment:2hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone |
Permissive
|
Homo sapiens |
GSE110800
...
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
Treatment:4hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone |
Permissive
|
Homo sapiens |
GSE110800
...
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
Treatment: etoposide (100uM, 6hrs) Source: IMR90 fetal lung fibroblasts Passage: #30-35 |
Permissive
Robust
|
Homo sapiens |
GSE115940
...
|
MA0106.3
|
TP53 |
SW480 (colon adenocarcinoma) |
treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable control (LacZ) knockdown |
Permissive
|
Homo sapiens |
GSE115985
...
|
MA0106.3
|
TP53 |
SW480 (colon adenocarcinoma) |
treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable p53 knockdown |
Permissive
|
Homo sapiens |
GSE115985
...
|
MA0106.3
|
TP53 |
HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells |
Treatment: no treatment, control |
Permissive
|
Homo sapiens |
GSE83317
...
|
MA0106.3
|
TP53 |
LOXIMVI |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
UO31 |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
A498 |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
Treatment: 4GY for 2hrs; |
Permissive
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
SK-MEL-5 (Cutaneous melanoma) |
Treatment: 4GY for 2hrs; |
Permissive
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
MALME3 |
Treatment: 4GY for 2hrs; |
Permissive
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
NCI-H460 (Large cell lung carcinoma) |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
A549 (lung carcinoma) |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
UACC62 |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
UACC257 |
Treatment: 4GY for 2hrs; |
Permissive
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
UACC257 |
Treatment: 4GY for 2hrs; |
Permissive
Robust
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
RPE |
Treatment: 4GY for 2hrs; |
Permissive
|
Homo sapiens |
GSE100292
...
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
Treatment: DMSO for 6hrs; Passage: 30-35; |
Permissive
Robust
|
Homo sapiens |
GSE58740
...
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
Treatment: nutlin3a (5uM final) for 6hrs; Passage: 30-35; |
Permissive
Robust
|
Homo sapiens |
GSE58740
...
|
MA0106.3
|
TP53 |
foreskin fibroblast |
Treatment: DMSO for 6 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE111009
...
|
MA0106.3
|
TP53 |
foreskin fibroblast |
Treatment: 5 uM Nutlin3A for 6 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE111009
...
|
MA0106.3
|
TP53 |
MCF10A (breast epithelial cells) |
Treatment: DMSO for 6 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE111009
...
|
MA0106.3
|
TP53 |
MCF10A (breast epithelial cells) |
Treatment: 5 uM Nutlin3A for 6 hrs; |
Permissive
Robust
|
Homo sapiens |
GSE111009
...
|
MA0106.3
|
TP53 |
foreskin fibroblast |
Treatment: DMSO for 6 hrs; |
Permissive
|
Homo sapiens |
GSE111009
...
|
MA0106.3
|
TP53 |
NMuMG (mammary epithelial cells) |
Treatment: not treated, not infectred; |
Permissive
Robust
|
Mus musculus |
GSE87002
...
|
MA0106.3
|
TP53 |
NMuMG (mammary epithelial cells) |
Treatment: 0.5 uM Adriamycin for 8hrs, not infectred; |
Permissive
Robust
|
Mus musculus |
GSE87002
...
|
MA0106.3
|
TP53 |
NMuMG (mammary epithelial cells) |
Treatment: not treated, infected with L-pWPI empy vector; |
Permissive
|
Mus musculus |
GSE87002
...
|
MA0106.3
|
TP53 |
NMuMG (mammary epithelial cells) |
Treatment: not treated, infected with L-pWPI-MycER; |
Permissive
|
Mus musculus |
GSE87002
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
NUT |
Permissive
Robust
|
Homo sapiens |
GSE47041
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
IR |
Permissive
|
Homo sapiens |
GSE60267
|
MA0106.3
|
TP53 |
E15.5 embryonic kidney |
|
Permissive
|
Mus musculus |
GSE49916
...
|
MA0106.3
|
TP53 |
BJ (fibroblasts) |
|
Permissive
|
Homo sapiens |
GSE20076
...
|
MA0106.3
|
TP53 |
fibroblasts |
|
Permissive
|
Homo sapiens |
GSE36749
...
|
MA0106.3
|
TP53 |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE66543
...
|
MA0106.3
|
TP53 |
MDA231-LM2-4175 (breast adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE95303
...
|
MA0106.3
|
TP53 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE109481
...
|
MA0106.3
|
TP53 |
SaOS2 (osteosarcoma) |
|
Permissive
|
Homo sapiens |
ERP002038
|
MA0106.3
|
TP53 |
NCI-H1299 (large cell lung carcinoma) |
|
Permissive
|
Homo sapiens |
ERP022459
|
MA0106.3
|
TP53 |
SaOS2 (osteosarcoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE15780
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
|
Permissive
Robust
|
Homo sapiens |
GSE31558
|
MA0106.3
|
TP53 |
H9 |
|
Permissive
|
Homo sapiens |
GSE39912
|
MA0106.3
|
TP53 |
SaOS2 (osteosarcoma) |
|
Permissive
|
Homo sapiens |
GSE51268
|
MA0106.3
|
TP53 |
GM00011 (fetal skin fibroblasts) |
|
Permissive
Robust
|
Homo sapiens |
GSE55727
|
MA0106.3
|
TP53 |
GM06170 (fetal skin fibroblasts) |
|
Permissive
Robust
|
Homo sapiens |
GSE55727
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE58714
|
MA0106.3
|
TP53 |
|
|
Permissive
|
Homo sapiens |
GSE59176
|
MA0106.3
|
TP53 |
|
|
Permissive
|
Homo sapiens |
GSE59176
|
MA0106.3
|
TP53 |
|
|
Permissive
Robust
|
Homo sapiens |
GSE59176
|
MA0106.3
|
TP53 |
|
|
Permissive
|
Homo sapiens |
GSE59176
|
MA0106.3
|
TP53 |
HepG2 (hepatoblastoma) |
|
Permissive
|
Homo sapiens |
GSE64877
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
UV_16H |
Permissive
Robust
|
Homo sapiens |
ERP004176
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
UV_8H |
Permissive
Robust
|
Homo sapiens |
ERP004176
|
MA0106.3
|
TP53 |
|
NUT |
Permissive
Robust
|
Homo sapiens |
ERP014035
|
MA0106.3
|
TP53 |
|
TPA_24H |
Permissive
|
Homo sapiens |
ERP014035
|
MA0106.3
|
TP53 |
|
TPA_4H |
Permissive
|
Homo sapiens |
ERP014035
|
MA0106.3
|
TP53 |
hESC-1 (Embryonic stem cells) |
DAMAGED |
Permissive
Robust
|
Homo sapiens |
GSE39912
|
MA0106.3
|
TP53 |
hESC-1 (Embryonic stem cells) |
DIFF |
Permissive
|
Homo sapiens |
GSE39912
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
SENES_SHLUC |
Permissive
|
Homo sapiens |
GSE42728
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
SENES_SHP53 |
Permissive
|
Homo sapiens |
GSE42728
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE46641
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
DXR |
Permissive
Robust
|
Homo sapiens |
GSE46641
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
NUT |
Permissive
Robust
|
Homo sapiens |
GSE46641
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
APO |
Permissive
|
Homo sapiens |
GSE53491
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
SENE |
Permissive
|
Homo sapiens |
GSE53491
|
MA0106.3
|
TP53 |
keratinocytes |
ADRIA |
Permissive
Robust
|
Homo sapiens |
GSE56674
|
MA0106.3
|
TP53 |
keratinocytes |
CISP |
Permissive
Robust
|
Homo sapiens |
GSE56674
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
5FU |
Permissive
Robust
|
Homo sapiens |
GSE58506
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE58740
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
NUT3A |
Permissive
Robust
|
Homo sapiens |
GSE58740
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
CAMP |
Permissive
|
Homo sapiens |
GSE74355
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
DMSO_KOATF3 |
Permissive
Robust
|
Homo sapiens |
GSE74355
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
|
Permissive
|
Homo sapiens |
ERP004176
|
MA0106.3
|
TP53 |
IMR90 (lung fibroblasts) |
|
Permissive
|
Homo sapiens |
GSE42728
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
|
Permissive
|
Homo sapiens |
GSE46641
|
MA0106.3
|
TP53 |
keratinocytes |
|
Permissive
Robust
|
Homo sapiens |
GSE56674
|
MA0106.3
|
TP53 |
HCT-116 (colon carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE58506
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
ETO |
Permissive
Robust
|
Homo sapiens |
GSE21939
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
ACTD |
Permissive
Robust
|
Homo sapiens |
GSE21939
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
ACTD |
Permissive
Robust
|
Homo sapiens |
GSE21939
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
ACTD |
Permissive
|
Homo sapiens |
GSE21939
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
ETO |
Permissive
Robust
|
Homo sapiens |
GSE21939
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
ETO |
Permissive
Robust
|
Homo sapiens |
GSE21939
|
MA0106.3
|
TP53 |
U2OS (osteosarcoma) |
ETO |
Permissive
Robust
|
Homo sapiens |
GSE21939
|
MA0106.3
|